Rare diseases as a strategic driver of Europe’s biotech leadership ++

https://www.europeanfiles.eu/health/rare-diseases-as-a-strategic-driver-of-europes-biotech-leadership Published in the July issue of the European Files "Revolution: Europe's Quest for Health Sovereignty", an article written by EURORDIS President Avril Daly examines how the proposed European Biotech Act I can help strengthen Europe's global leadership in biotechnology by placing rare diseases at the heart of innovation. Avril argues that rare diseases have long driven breakthroughs in areas such as genomics, advanced therapies and precision medicine, and calls on policymakers to ensure the Biotech Act supports the research, investment and collaboration needed to translate scientific advances into better outcomes for patients. https://www.europeanfiles.eu/magazine/europes-quest-for-health-sovereignty-building-the-next-generation-of-biotechnology